CClinicalTrials.gg
Not yet recruitingNCT07034833PuppetsUpdated Jun 24, 2025

Assessment of a Ventriloquist Puppet for Reducing Dental Anxiety in Children

An interventional study of Ventriloquist Puppet Interaction in Dental Anxiety, sponsored by Al-Azhar University. Not yet recruiting. Open to participants aged 5 Years to 10 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-24.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 3 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
5 Years to 10 Years
Sex
All
01

Study summary

thhe goal of this clinical trial is to assess the effect of ventriloquist puppets to reduce the strees accompined by the dental visit in cgilren . The main questions it aims to answer are:

  • Does the ventriloquist puppet can reduce the stress accompanied by the dental visit for the children ?
  • What medical problems do participants have when taking drug ABC? Researchers will compare ventriloquist puppet to a control group (conventional behavior management techniques ) to see if ventriloquist puppet can lower the anxiety or not.
02

Conditions studied

  • Dental Anxiety

Keywords

  • dental anxiety
  • behavior management
03

In context

Lead sponsor

Al-Azhar University is the lead sponsor of 505 studies on the registry; 167 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • healthy children with no systemic diseases.
  • children require dental intervention

Exclusion criteria

Exclusion Criteria:

  • children with bad dental experience
  • children require invasive surgical intervention
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • No intervention
    control group: 25 child managed by basic behavior management tecniques

    this group managed normaly with the basic behavior managment techniques like tell , show , do and others

  • Active comparator
    puppet therapy group: Children allocated to the Ventriloquist Puppet group

    Children allocated to the Ventriloquist Puppet group were introduced to a Ventriloquist Puppet inside the clinic and were allowed to play , talk and interact with the puppet for five to 10 min

    Behavioral: Ventriloquist Puppet Interaction

Interventions

  • BehavioralVentriloquist Puppet Interaction

    children allocated to the Ventriloquist Puppet group were introduced to a Ventriloquist Puppet inside the clinic and were allowed to play, talk, and interact with the puppet for 5-10 minutes.

06

What researchers measure

Primary outcomes

  1. Dental anxiety

    Change in Anxiety Score using MCDAS scale

    Time frame: From immediately before to immediately after the dental procedure

  2. Heart rate

    change in heart rate during the visit to investigate the anxiety effect using pulse oximeter

    Time frame: From immediately before to immediately after the dental procedure

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07034833
Lead sponsor
Al-Azhar University
Responsible party
Hamdy Badreldin (lecturer of pediatric dentistry and oral health, Al-Azhar University) — Principal investigator
First posted
Jun 24, 2025
Start date
Jun 23, 2025 (estimated)
Primary completion
Jul 1, 2025 (estimated)
Completion
Jul 10, 2025 (estimated)
Last update
Jun 24, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion